Established in 1996, Korea Clinical Laboratory (KCL) is a research-oriented medical foundation, as well as a medical laboratory, which swiftly and accurately conducts various professional clinical tests specializing in diagnostic tests, diagnostic pathology tests, and molecular diagnostic tests. KCL obtained a certificate as a contract research organization in 1996, was selected as an excellent test organization by the Korean Association of External Quality Assessment Service in 1999, and conducted medical laboratory tests for about 1,700 clinics and hospitals in Seoul and Gyeonggi Province. KCL was also selected as an excellent test organization by the Korean Society for Laboratory Medicine in 2000. KCL established the Phil Hospital in Jeongeup (city) in North Jeolla Province in 2004. The Phil Hospital founded its branch hospitals in Daegu, Daejeon, and Suwon (cities) in 2008. KCL merged with Hamchoon Clinical Laboratory in 2008, and acquired the department in charge of contract research from the Dong-a Medical Foundation and merged with CSL, a diagnostic organization specializing in cervical cancer, and the Sekang Hospital in 2012.
While Mr. Kim majored in electronic engineering, his career began in a field unrelated to his major. He worked in fields unrelated to diagnostic testing for several years, before he began his career in diagnostic testing by chance. In 1996, along with his colleagues, Mr. Kim established Korea Clinical Laboratory (KCL) and began to provide healthcare services, including diagnostic tests. With his vision of the promising future in diagnostic tests, he has developed KCL into one of the best private medical foundations during the last 20 years. He founded KCL to realize the fundamental value of ‘respecting life’ and provide high-quality medical services. To realize the vision, Mr. Kim provides high-quality test services to hospitals and patients via efficient organization management, profound knowledge of medicine, and experienced pathology specialists specializing in diagnostic tests while promoting the value of sustainable development.
Mr. Sung stands alone with a degree in hospital administration among Korea's chief executive officers of commercial laboratories. After joining Dong-A Pharmaceutical in 1989, he worked in the Diagnostics Department providing healthcare services, and established Sun Phil Clinical Medicine Laboratory in 2000. Mr. Sung became the CEO of the Dong-a Medical Foundation in 2004, and then established KCL with Mr. Kim following an M&A among diagnostics service providers. He serves as a joint manager and COO of KCL to utilize his expertise in hospital management. As a prominent and respected leader in the Diagnostic industry in Korea, Mr Sung speaks and presents to his peers on Abbott's unique TCO philosophy and the results it generates.
Before joining KCL in 2014, Ms. Cho worked at Sekang Hospital. She believed that large medical laboratories could not cover all hospitals and clinics in Korea, and thus small and medium-sized laboratories should enhance their competitive edge to provide high-quality medical services. As the clinics owned by individuals and small-sized clinics face difficulty when communicating with laboratories, Mr. Cho is committed to providing test results more swiftly, offering new information to help customers not be alienated from information, and developing expertise while growing together with customers, which will lead to improvement in the quality of services offered to patients.
